Interested in shaping future narcolepsy drug development? Here’s your chance! On September 24, 2013, FDA will host the Narcolepsy Public Meeting to obtain patients’ perspectives on the impact of narcolepsy on daily life as well as the available therapies for narcolepsy.
This past year, we worked together to secure this tremendous opportunity with FDA. The September 24 meeting gives patients the power to shape the future of narcolepsy drug development.
Patient participation will be essential for success. Patients can contribute in person, via webcast or public docket.
I am working with policy experts on an exciting plan of action. Details coming soon! Please feel free to contact me (email@example.com) if you’re interested in getting involved or have any questions.
Save the Date:
When: September 24, 2013 from 1:00 PM to 5:00 PM (EDT)
What: FDA Narcolepsy Public Meeting on Patient-Focused Drug Development
Where: Attend in person OR by webcast – REGISTRATION is FREE (register by Sept. 13, 2013)
FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Room 1503 A
Silver Spring, MD 20993
Who: Narcolepsy Patients & Patient Stakeholders
Why: To help shape future narcolepsy treatment options by providing FDA with patient perspective on the impact of narcolepsy on daily life as well as the available therapies.
For more about the FDA Initiative, click here.